Evidence map›Paper›PMID 40563587›Full record

ArticleCancers2025

Somatostatin Receptor Expression of Gastroenteropancreatic Neuroendocrine Tumors: A Comprehensive Analysis in the Era of Somatostatin Receptor PET Imaging.

Maria Grazia Maratta, Taymeyah Al-Toubah, Jaime Montilla-Soler, Eleonora Pelle, Mintallah Haider, Ghassan El-Haddad, Jonathan Strosberg

Abstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Development of dual SSTRSC medicinal chemistry · 2026
    Article
  3. Head-to-head comparison of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Frontiers in endocrinology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Maria Grazia MarattaComprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.ORCID 0000-0002-8057-6629
Taymeyah Al-ToubahDepartment of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.ORCID 0000-0003-1488-2414
Jaime Montilla-SolerDepartment of Diagnostic Imaging and Nuclear Medicine, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.
Eleonora PelleDepartment of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.
Mintallah HaiderDepartment of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.
Ghassan El-HaddadDepartment of Diagnostic Imaging and Nuclear Medicine, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.
Jonathan StrosbergDepartment of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.ORCID 0000-0001-8405-218X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

64Cu-DOTATATE68Ga-DOTATATEGastroenteropancreatic NETneuroendocrine tumorsomatostatin receptor

Identifiers

PMID40563587
PMCPMC12190786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.